The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
Open accessAbstract
This review is an updated and expanded version of the five prior reviews that were published in this journal in 1997, 2003, 2007, 2012, and 2016. For all approved therapeutic agents, the time frame has been extended to cover the almost 39 years from the first of January 1981 to the 30th of September 2019 for all diseases worldwide and from ∼1946 (earliest so far identified) to the 30th of September 2019 for all approved antitumor drugs worldwide. As in earlier reviews, only the first approval of any drug is counted, irrespective of how many "biosimilars" or added approvals were subsequently identified. As in the 2012 and 2016 reviews, we have continued to utilize our secondary subdivision of a "natural product mimic", or "NM", to join the original primary divisions, and the designation "natural product botanical", or "NB", to cover those botanical "defined mixtures" now recognized as drug entities by the FDA (and similar organizations). From the data presented in this review, the utilization of natural products and/or synthetic variations using their novel structures, in order to discover and develop the final drug entity, is still alive and well. For example, in the area of cancer, over the time frame from 1946 to 1980, of the 75 small molecules, 40, or 53.3%, are N or ND. In the 1981 to date time frame the equivalent figures for the N* compounds of the 185 small molecules are 62, or 33.5%, though to these can be added the 58 S* and S*/NMs, bringing the figure to 64.9%. In other areas, the influence of natural product structures is quite marked with, as expected from prior information, the anti-infective area being dependent on natural products and their structures, though as can be seen in the review there are still disease areas (shown in Table 2) for which there are no drugs derived from natural products. Although combinatorial chemistry techniques have succeeded as methods of optimizing structures and have been used very successfully in the optimization of many recently approved agents, we are still able to identify only two de novo combinatorial compounds (one of which is a little speculative) approved as drugs in this 39-year time frame, though there is also one drug that was developed using the "fragment-binding methodology" and approved in 2012. We have also added a discussion of candidate drug entities currently in clinical trials as "warheads" and some very interesting preliminary reports on sources of novel antibiotics from Nature due to the absolute requirement for new agents to combat plasmid-borne resistance genes now in the general populace. We continue to draw the attention of readers to the recognition that a significant number of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated"; thus we consider that this area of natural product research should be expanded significantly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This diversity of plants and secondary metabolites present in these plants indicates tremendous possibilities for drug discovery and development [3,4].”
From Yellow Himalayan Raspberry (Rubus ellipticus Sm.): Ethnomedicinal, Nutraceutical, and Pharmacological Aspects (2023) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lead- and drug-like compounds: the rule-of-five revolution
Lipinski, C. A. (2004) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2004.11.007 · Cited by 6,199
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Self-citationNatural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Self-citationLiu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687
Self-citationNatural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082
Self-citationNatural products: A continuing source of novel drug leads
Cragg, G. M., & Newman, D. J. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.02.008 · Cited by 2,906
Self-citationA new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Mueller, A., Schäberle, T. F., Hughes, D. E., Epstein, S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
Natural Products in Drug Discovery and Development
Cragg, G. M., Newman, D. J., & Snader, K. M. (1997) · Journal of Natural Products · doi:10.1021/np9604893 · Cited by 1,585
Self-citationMartindale: The Complete Drug Reference
O’Rourke, A. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/br090004 · Cited by 1,190
Cited by
Natural products in drug discovery: advances and opportunities
Atanasov, A. G., Zotchev, S. B., Dirsch, V. M., Taskforce, T. I. N. P. S., Orhan, I. E., Banach, M., Rollinger, J. M., Barreca, D., Weckwerth, W., Bauer, R., et al. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00114-z · Cited by 5,392
antiSMASH 6.0: improving cluster detection and comparison capabilities
Blin, K., Shaw, S., Kloosterman, A. M., Charlop-Powers, Z., van Wezel, G. P., Medema, M. H., & Weber, T. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab335 · Cited by 2,562
Blin, K., Shaw, S., Augustijn, H. E., Reitz, Z. L., Biermann, F., Alanjary, M., Fetter, A., Terlouw, B. R., Metcalf, W. W., Helfrich, E. J. N., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad344 · Cited by 2,290
Towards the sustainable discovery and development of new antibiotics
Miethke, M., Pieroni, M., Weber, T., Brönstrup, M., Hammann, P., Halby, L., Arimondo, P. B., Glaser, P., Aigle, B., Bode, H. B., et al. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00313-1 · Cited by 1,151
Marshall, C. M., Federice, J. G., Bell, C. N., Cox, P. B., & Njardarson, J. T. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01122 · Cited by 1,064
Blin, K., Shaw, S., Vader, L., Szenei, J., Reitz, Z. L., Augustijn, H. E., Cediel-Becerra, J. D. D., de Crécy-Lagard, V., Koetsier, R. A., Williams, S. E., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf334 · Cited by 671
Natural Products in Cancer Therapy: Past, Present and Future
Huang, M., Lu, J.-J., & Ding, J. (2021) · Natural Products and Bioprospecting · doi:10.1007/s13659-020-00293-7 · Cited by 648
Natural Products as Anticancer Agents: Current Status and Future Perspectives
Naeem, A., Hu, P., Yang, M., Zhang, J., Liu, Y., Zhu, W., & Zheng, Q. (2022) · Molecules · doi:10.3390/molecules27238367 · Cited by 607
Pant, P., Pandey, S., & Dall'Acqua, S. (2021) · Chemistry & Biodiversity · doi:10.1002/cbdv.202100345 · Cited by 590
Advances in the E → Z Isomerization of Alkenes Using Small Molecule Photocatalysts
Neveselý, T., Wienhold, M., Molloy, J. J., & Gilmour, R. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00324 · Cited by 506
Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy
Dehelean, C. A., Marcovici, I., Soica, C., Mioc, M., Coricovac, D., Iurciuc, S., Cretu, O. M., & Pinzaru, I. (2021) · Molecules · doi:10.3390/molecules26041109 · Cited by 502
Yeshi, K., Crayn, D., Ritmejerytė, E., & Wangchuk, P. (2022) · Molecules · doi:10.3390/molecules27010313 · Cited by 488
Artificial intelligence for natural product drug discovery
Mullowney, M. W., Duncan, K. R., Elsayed, S. S., Garg, N., van der Hooft, J. J. J., Martin, N. I., Meijer, D., Terlouw, B. R., Biermann, F., Blin, K., et al. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00774-7 · Cited by 460
Elshafie, H. S., Camele, I., & Mohamed, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043266 · Cited by 439
Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells
Wei, R., Zhao, Y., Wang, J., Yang, X., Li, S., Wang, Y., Yang, X., Fei, J., Hao, X., Zhao, Y., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59404 · Cited by 434
Vaou, N., Stavropoulou, E., Voidarou, C. (., Tsakris, Z., Rozos, G., Tsigalou, C., & Bezirtzoglou, E. (2022) · Antibiotics · doi:10.3390/antibiotics11081014 · Cited by 406
Heinrich, M., Jalil, B., Abdel-Tawab, M., Echeverria, J., Kulić, Ž., McGaw, L. J., Pezzuto, J. M., Potterat, O., & Wang, J.-B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.953205 · Cited by 393
Chunarkar-Patil, P., Kaleem, M., Mishra, R., Ray, S., Ahmad, A., Verma, D., Bhayye, S., Dubey, R., Singh, H., & Kumar, S. (2024) · Biomedicines · doi:10.3390/biomedicines12010201 · Cited by 390
Biosynthetic potential of the global ocean microbiome
Paoli, L., Ruscheweyh, H.-J., Forneris, C. C., Hubrich, F., Kautsar, S., Bhushan, A., Lotti, A., Clayssen, Q., Salazar, G., Milanese, A., et al. (2022) · Nature · doi:10.1038/s41586-022-04862-3 · Cited by 384
Ethnobotany and the Role of Plant Natural Products in Antibiotic Drug Discovery
Porras, G., Chassagne, F., Lyles, J. T., Marquez, L., Dettweiler, M., Salam, A. M., Samarakoon, T., Shabih, S., Farrokhi, D. R., & Quave, C. L. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00922 · Cited by 378
IMPPAT 2.0: An Enhanced and Expanded Phytochemical Atlas of Indian Medicinal Plants
Vivek-Ananth, R. P., Mohanraj, K., Sahoo, A. K., & Samal, A. (2023) · ACS Omega · doi:10.1021/acsomega.3c00156 · Cited by 372
m6A modification: recent advances, anticancer targeted drug discovery and beyond
Deng, L.-J., Deng, W.-Q., Fan, S.-R., Chen, M.-F., Qi, M., Lyu, W.-Y., Qi, Q., Tiwari, A. K., Chen, J.-X., Zhang, D.-M., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01510-2 · Cited by 366
Kaempferol: Antimicrobial Properties, Sources, Clinical, and Traditional Applications
Periferakis, A., Periferakis, K., Badarau, I. A., Petran, E. M., Popa, D. C., Caruntu, A., Costache, R. S., Scheau, C., Caruntu, C., & Costache, D. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315054 · Cited by 362
Hou, W., & Xu, H. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01859 · Cited by 335
Compendium of specialized metabolite biosynthetic diversity encoded in bacterial genomes
Gavriilidou, A., Kautsar, S. A., Zaburannyi, N., Krug, D., Müller, R., Medema, M. H., & Ziemert, N. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01110-2 · Cited by 326
Macrocycles in Drug Discovery─Learning from the Past for the Future
Garcia Jimenez, D., Poongavanam, V., & Kihlberg, J. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00134 · Cited by 321
Paclitaxel: Application in Modern Oncology and Nanomedicine‐Based Cancer Therapy
Sharifi-Rad, J., Quispe, C., Patra, J. K., Singh, Y. D., Panda, M. K., Das, G., Adetunji, C. O., Michael, O. S., Sytar, O., Polito, L., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3687700 · Cited by 298
Stan, D., Enciu, A.-M., Mateescu, A. L., Ion, A. C., Brezeanu, A. C., Stan, D., & Tanase, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.723233 · Cited by 269
Lyu, C., Chen, T., Qiang, B., Liu, N., Wang, H., Zhang, L., & Liu, Z. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa763 · Cited by 265
Diosgenin: An Updated Pharmacological Review and Therapeutic Perspectives
Semwal, P., Painuli, S., Abu-Izneid, T., Rauf, A., Sharma, A., Daştan, S. D., Kumar, M., Alshehri, M. M., Taheri, Y., Das, R., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1035441 · Cited by 195
A marine microbiome antifungal targets urgent-threat drug-resistant fungi
Zhang, F., Zhao, M., Braun, D. R., Ericksen, S. S., Piotrowski, J. S., Nelson, J., Peng, J., Ananiev, G. E., Chanana, S., Barns, K., et al. (2020) · Science · doi:10.1126/science.abd6919 · Cited by 177
Wieczorek, P. P., Hudz, N., Yezerska, O., Horčinová-Sedláčková, V., Shanaida, M., Korytniuk, O., & Jasicka-Misiak, I. (2022) · Molecules · doi:10.3390/molecules27051600 · Cited by 133
Advancing pharmaceutical research: A comprehensive review of cutting-edge tools and technologies
Chen, J., Lin, A., & Luo, P. (2024) · Current Pharmaceutical Analysis · doi:10.1016/j.cpan.2024.11.001 · Cited by 112
Computer especially AI-assisted drug virtual screening and design in traditional Chinese medicine
Lin, Y., Zhang, Y., Wang, D., Yang, B., & Shen, Y.-Q. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154481 · Cited by 107
Myricetin: Targeting signaling networks in cancer and its implication in chemotherapy
Javed, Z., Khan, K., Herrera-Bravo, J., Naeem, S., Iqbal, M. J., Raza, Q., Sadia, H., Raza, S., Bhinder, M., Calina, D., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02663-2 · Cited by 93
A Review on Annona muricata and Its Anticancer Activity
Ilango, S., Sahoo, D. K., Paital, B., Kathirvel, K., Gabriel, J. I., Subramaniam, K., Jayachandran, P., Dash, R. K., Hati, A. K., Behera, T. R., et al. (2022) · Cancers · doi:10.3390/cancers14184539 · Cited by 91
Niazi, S. K. (2025) · Pharmaceuticals · doi:10.3390/ph18091271 · Cited by 61
Jin, J., Wu, Y., Zhao, Z., Wu, Y., Zhou, Y.-D., Liu, S., Sun, Q., Yang, G., Lin, J., Nagle, D. G., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.160606 · Cited by 57
“Inspired by the chemical structure diversity and biological activity of natural products (29), it was proposed that PROT-AC molecules should be designed based on natural molecules as a new strategy to effectively target STAT3, especially exploring the application of STAT3 degrader in solid tumors.”
Nguyen, D. T., Zhu, L., Gray, D. L., Woods, T. J., Padhi, C., Flatt, K. M., Mitchell, D. A., & van der Donk, W. A. (2024) · ACS Central Science · doi:10.1021/acscentsci.4c00088 · Cited by 51
Silva, M. R. O. B. D., M. da Silva, G., Silva, A. L. F. D., Lima, L. R. A. D., Bezerra, R. P., & Marques, D. D. A. V. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00568 · Cited by 51
Native metabolomics identifies the rivulariapeptolide family of protease inhibitors
Reher, R., Aron, A. T., Fajtová, P., Stincone, P., Wagner, B., Pérez-Lorente, A. I., Liu, C., Shalom, I. Y. B., Bittremieux, W., Wang, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32016-6 · Cited by 53
Integrated Metabolomic–Genomic Workflows Accelerate Microbial Natural Product Discovery
Avalon, N. E., Murray, A. E., & Baker, B. J. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c02245 · Cited by 47
Conceição, M., Gushiken, L. F. S., Aldana-Mejía, J. A., Tanimoto, M. H., Ferreira, M. V. D. S., Alves, A. C. M., Miyashita, M. N., Bastos, J. K., Beserra, F. P., & Pellizzon, C. H. (2022) · Antioxidants · doi:10.3390/antiox11112188 · Cited by 34
Recent advances of tanshinone in regulating autophagy for medicinal research
Wu, S., Zhao, K., Wang, J., Liu, N., Nie, K., Qi, L., & Xia, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1059360 · Cited by 32
Antioxidant activity of the main phenolics found in red fruits: An in vitro and in silico study
Gonçalves, A. C., Falcão, A., Alves, G., Silva, L. R., & Flores-Félix, J. D. (2024) · Food Chemistry · doi:10.1016/j.foodchem.2024.139459 · Cited by 28
Lamichhane, A., Lamichhane, G., & Devkota, H. P. (2023) · Molecules · doi:10.3390/molecules28166071 · Cited by 28
Masi, M., Koirala, M., Delicato, A., Di Lecce, R., Merindol, N., Ka, S., Seck, M., Tuzi, A., Desgagne-Penix, I., Calabrò, V., et al. (2021) · Biomolecules · doi:10.3390/biom11091298 · Cited by 25
Do Bacteria Provide an Alternative to Cancer Treatment and What Role Does Lactic Acid Bacteria Play?
Dicks, L. M. T., & Vermeulen, W. (2022) · Microorganisms · doi:10.3390/microorganisms10091733 · Cited by 25
Molimau-Samasoni, S., Woolner, V. H., Foliga, S. T., Robichon, K., Patel, V., Andreassend, S. K., Sheridan, J. P., Te Kawa, T., Gresham, D., Miller, D., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100880118 · Cited by 20
Rodriguez-Gonzalez, J. C., Hernández-Balmaseda, I., Declerck, K., Pérez-Novo, C., Logie, E., Theys, C., Jakubek, P., Quiñones-Maza, O. L., Dantas-Cassali, G., Carlos dos Reis, D., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.670167 · Cited by 19
Methylotroph Quorum Sensing Signal Identification by Inverse Stable Isotopic Labeling
Cummings, D. A., Snelling, A. I., & Puri, A. W. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00329 · Cited by 12
Argentatin Content in Guayule Leaves (Parthenium argentatum A. Gray)
García-Martínez, M. M., Gallego, B., Latorre, G., Carrión, M. E., De la Cruz-Morcillo, M. Á., Zalacain, A., & Carmona, M. (2023) · Plants · doi:10.3390/plants12102021 · Cited by 8
Xie, F., Kiefer, A. F., Hirsch, A. K. H., Kalinina, O. V., Fu, C., & Müller, R. (2023) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2023.101394 · Cited by 5
A methoxylated flavone from Artemisia afra kills Mycobacterium tuberculosis
Kellogg, J. J., Alonso, M. N., Jordan, R. T., Xiao, J., Cafiero, J. H., Bush, T., Towler, M., Weathers, P., & Shell, S. S. (2023) · doi:10.1101/2023.10.11.561885 · Cited by 3
Prasetiya, F. S., Destiarani, W., Prihastaningtyas, I. R. C., Agung, M. U. K., & Yusuf, M. (2023) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2023.10012 · Cited by 3
Cordero-Riande, C. A., Monforte-Gonzalez, M., Echevarria-Machado, I., Derbré, S., Herbert-Doctor, L. A., & Peña-Rodríguez, L. M. (2025) · Journal of Chromatography A · doi:10.1016/j.chroma.2025.466255
Metadata
- Authors
- Newman, D. J., & Cragg, G. M.
- Venue
- Journal of Natural Products
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-03-12
- Volume
- 83
- Issue
- 3
- Pages
- 770-803
- ISSN
- 0163-3864 (ISSN-L)
- 1520-6025
- OpenAlex
- W3011366455
- Cited by
- 7,015
- References
- 104
- FWCI
- 388.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.